Advertisement
Singapore markets closed
  • Straits Times Index

    3,410.81
    -29.07 (-0.85%)
     
  • Nikkei

    40,912.37
    -1.28 (-0.00%)
     
  • Hang Seng

    17,799.61
    -228.67 (-1.27%)
     
  • FTSE 100

    8,203.93
    -37.33 (-0.45%)
     
  • Bitcoin USD

    56,401.07
    -1,900.77 (-3.26%)
     
  • CMC Crypto 200

    1,170.85
    -37.85 (-3.13%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • Dow

    39,375.87
    +67.87 (+0.17%)
     
  • Nasdaq

    18,352.76
    +164.46 (+0.90%)
     
  • Gold

    2,399.30
    +29.90 (+1.26%)
     
  • Crude Oil

    83.32
    -0.56 (-0.67%)
     
  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     
  • FTSE Bursa Malaysia

    1,611.02
    -5.73 (-0.35%)
     
  • Jakarta Composite Index

    7,253.37
    +32.48 (+0.45%)
     
  • PSE Index

    6,492.75
    -14.74 (-0.23%)
     

Artisan Investments raises stake in Philips to 10%, regulatory filing shows

Philips Healthcare headquarters is seen in Best

AMSTERDAM (Reuters) - U.S. asset management firm Artisan Investments has raised its stake in Philips to 10%, sending the healthcare technology group's shares rising on Wednesday, a week after the Dutch company's biggest shareholder also increased its holding.

At 1045 GMT, Philips shares were up 1.66% at 23.90 euros, outperforming the Dutch stock market blue-chip AEX (+1.05%) as well as the Stoxx Europe 600 healthcare index (-0.1%).

After raising its stake, Artisan Investments now owns 94.13 million shares in Philips, or about 10% of the company, according to a regulatory filing published earlier.

"Artisan has owned more than 9% in Philips for quite some time and has recently increased their stake to 10% after (our) Q1 results. We see this as a signal of trust in our strategy and plan," a Philips spokesperson told Reuters.

ADVERTISEMENT

Artisan Investments is now Philips' second-largest shareholder behind Exor, the investment arm of Italy's Agnelli family, which increased its stake to 17.51% last week.

Philips reported a better-than-expected first-quarter profit on April 29, with its adjusted earnings before interest, taxes and amortisation (EBITA) jumping 8% to 388 million euros ($417.22 million).

The company also announced a smaller-than-expected settlement on the same day to resolve claims over recalled breathing devices in the U.S.

($1 = 0.9300 euros)

(Reporting by Toby Sterling and Benoit Van Overstraeten; Editing by Louise Heavens and Anil D'Silva)